Literature DB >> 11707929

Zinc, metallothioneins, immune responses, survival and ageing.

E Mocchegiani1, M Muzzioli, R Giacconi.   

Abstract

Zinc is required as a catalytic, structural (zinc fingers) and regulatory ion. In this capacity, it is involved in many homeostatic mechanisms, including immune responses. Metallothioneins (MTs) may play key roles because of their preferential binding to zinc especially in ageing. MTs protect from oxidative damage during transient stress conditions at young-adult age. This protection no longer exists in ageing and in age-related diseases (cancer and infections) because the stress condition is constant. As such, MTs may constantly deplete zinc from plasma and tissues. This phenomenon causes increased MTs levels on the one hand, but on the other hand induces low zinc ion bioavailability for normal immune responses. This may be particularly relevant for thymic functions and natural killer activity. Therefore MTs which are protective in young-adults may become dangerous in immune responses during ageing. Physiological supplementation of zinc in ageing corrects central and peripheral immune defects, resulting prolonged survival and decreased mortality (50%) from infections and tumours, especially during middle age. Because of increased MT gene expression and protein levels in the liver and atrophic thymus of old mice, MTs are proposed as genetic markers of immunosenescence.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11707929     DOI: 10.1023/a:1010095930854

Source DB:  PubMed          Journal:  Biogerontology        ISSN: 1389-5729            Impact factor:   4.277


  16 in total

1.  Zinc and energy requirements in induction of oxidative stress to retinal pigmented epithelial cells.

Authors:  John P M Wood; Neville N Osborne
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

Review 2.  Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve.

Authors:  L C Costello; P Feng; B Milon; M Tan; R B Franklin
Journal:  Prostate Cancer Prostatic Dis       Date:  2004       Impact factor: 5.554

Review 3.  Dysregulation of T-cell function in the elderly : scientific basis and clinical implications.

Authors:  Tamas Fulop; Anis Larbi; Anders Wikby; Eugenio Mocchegiani; Katsuiku Hirokawa; Graham Pawelec
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  Age-related histological and zinc content changes in adult nonhyperplastic prostate glands.

Authors:  Vladimir Zaichick; Sofia Zaichick
Journal:  Age (Dordr)       Date:  2013-07-14

5.  The effects of zinc sulfate on the levels of some elements and oxidative stress occurring in lenses of rats exposed to total cranium radiotherapy.

Authors:  Mustafa Kandaz; Mustafa Vecdi Ertekin; Burak Erdemci; Ahmet Kızıltunç; İbrahim Koçer; Hilal Kızıltunç Özmen; Meryem Işık Aktan; Ayşe Vildan Beşe
Journal:  Eurasian J Med       Date:  2009-08

6.  Antiproliferative effects of zinc-citrate compound on hormone refractory prostate cancer.

Authors:  Sung Hoo Hong; Yong Sun Choi; Hyuk Jin Cho; Ji Youl Lee; Joon Chul Kim; Tae Kon Hwang; Sae Woong Kim
Journal:  Chin J Cancer Res       Date:  2012-06       Impact factor: 5.087

Review 7.  Heavy Metals and Human Health: Mechanistic Insight into Toxicity and Counter Defense System of Antioxidants.

Authors:  Arif Tasleem Jan; Mudsser Azam; Kehkashan Siddiqui; Arif Ali; Inho Choi; Qazi Mohd Rizwanul Haq
Journal:  Int J Mol Sci       Date:  2015-12-10       Impact factor: 5.923

Review 8.  Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-κB signaling.

Authors:  Magdalena Jarosz; Magdalena Olbert; Gabriela Wyszogrodzka; Katarzyna Młyniec; Tadeusz Librowski
Journal:  Inflammopharmacology       Date:  2017-01-12       Impact factor: 4.473

Review 9.  Immunosupportive therapies in aging.

Authors:  Tamas Fülöp; Anis Larbi; Katsuiku Hirokawa; Eugenio Mocchegiani; Bruno Lesourds; Stephen Castle; Anders Wikby; Claudio Franceschi; Graham Pawelec
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

10.  A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV.

Authors:  Larisa Kizima; Aixa Rodríguez; Jessica Kenney; Nina Derby; Olga Mizenina; Radhika Menon; Samantha Seidor; Shimin Zhang; Keith Levendosky; Ninochka Jean-Pierre; Pavel Pugach; Guillermo Villegas; Brian E Ford; Agegnehu Gettie; James Blanchard; Michael Piatak; Jeffrey D Lifson; Gabriela Paglini; Natalia Teleshova; Thomas M Zydowsky; Melissa Robbiani; José A Fernández-Romero
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.